Article Details
Retrieved on: 2022-04-10 20:04:12
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Long-term treatment with subcutaneous lumasiran (Oxlumo) significantly reduced urinary oxalate (UOx) excretion in patients with primary ...
Article found on: www.medpagetoday.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here